GO:0016531 copper chaperone activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016531 copper chaperone activity is a molecular function defined as directly binding to and delivering copper ions to a target protein.
• Copper chaperones such as CCS, Atox1, and SCO1 ensure copper is routed to specific cuproproteins rather than accumulating as free, toxic ions [1,2].
• CCS delivers copper to SOD1, and its dysfunction is linked to neurodegeneration and memory decline.
• Atox1 transfers copper to ATP7B and participates in copper-dependent signaling and disease [6,8].
• SCO1 functions in a mitochondrial copper delivery pathway that intersects with AMPK-LKB1 signaling and NAFLD biology.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of copper chaperone function in cells and animals [3,5].
Description
Copper chaperone activity (GO:0016531) is a molecular function in which a protein directly binds copper ions and delivers them to a target protein. This activity is essential because copper is both required for the catalytic function of many enzymes and potentially toxic when free or mislocalized [1,2]. Copper chaperones provide specificity and safety in intracellular copper trafficking, ensuring that cuproproteins such as SOD1, ATP7B, and cytochrome c oxidase subunits receive copper in a controlled manner [1,2,6]. Researchers study copper chaperone activity to understand how cells maintain copper homeostasis, how cuproprotein maturation is achieved, and how defects in these processes contribute to disease [1,8]. The QuickGO definition of GO:0016531 is directly binding to and delivering copper ions to a target protein, and this article focuses exclusively on that function and its associated genes, mechanisms, and experimental models.
copper chaperone activity At A Glance
| GO ID | GO:0016531 |
|---|---|
| GO term | copper chaperone activity |
| Ontology | molecular_function |
| Synonym | copper carrier activity |
| Definition | Directly binding to and delivering copper ions to a target protein. |
| Major function | Targeted delivery of copper ions to specific cuproproteins such as SOD1, ATP7B, and cytochrome c oxidase subunits. |
| Representative genes/proteins | CCS, Atox1, SCO1, SCO2, COX17, and related copper-binding proteins. |
| Associated processes | Copper homeostasis, cuproprotein maturation, redox regulation, mitochondrial function, and autophagy. |
| Disease relevance | Neurodegeneration, metabolic liver disease, and disorders of copper metabolism. |
What Is GO:0016531?
In simple terms, copper chaperone activity means a protein grabs a copper ion and hands it directly to another protein that needs it. According to the QuickGO definition, GO:0016531 describes the molecular function of directly binding to and delivering copper ions to a target protein. This is distinct from general copper transport or storage: the chaperone must physically interact with both copper and the recipient protein to facilitate metal transfer [1,6]. Copper chaperones are therefore central to the safe and targeted distribution of copper within cells [1,2].
Why Is copper chaperone activity Important in Cell Biology?
Copper chaperone activity is important because it determines whether copper reaches the correct protein targets without causing oxidative damage or interfering with other metal-dependent processes [1,2]. Dysregulation of copper chaperones has been linked to neurodegeneration, metabolic disease, and altered cell death pathways, making this function a key area for both mechanistic and therapeutic research [1,4,5,8].
• Copper chaperones prevent free copper from participating in harmful redox reactions [1,2].
• CCS-mediated copper delivery to SOD1 is required for SOD1 activity, and its reduction is associated with neurodegeneration and memory decline.
• Atox1 regulates the copper transporter ATP7B by modulating domain dynamics, linking chaperone function to copper export.
• SCO1 participates in a mitochondrial copper delivery pathway that intersects with AMPK-LKB1 signaling and NAFLD biology.
• Copper chaperone for SOD1 can transfer copper to mitochondria, connecting chaperone activity to mitochondrial function.
• Copper chaperone antioxidant 1 (Atox1) has multiple roles and is considered a potential therapeutic target.
• Copper metabolism, including chaperone-mediated delivery, is integrated with cell death and autophagy pathways.
• Golgi-targeted copper delivery strategies can enhance copper-dependent protein activity for tissue regeneration.
• Defects in copper chaperone function can contribute to cuproprotein misfolding and disease [1,4].
• CRISPR-based models allow causal testing of copper chaperone genes in disease-relevant contexts [3,5].
Molecular Mechanism of copper chaperone activity
Copper binding and chaperone activation
In simple terms: The chaperone first picks up a copper ion using special copper-binding sites.
Copper chaperones contain conserved copper-binding motifs, such as CxxC or related sequences, that coordinate Cu(I) with high affinity [1,6]. This binding step is required for the chaperone to adopt a conformation competent for target recognition and metal transfer. In the case of Atox1, copper binding modulates domain dynamics that are important for its function.
Target recognition and direct delivery
In simple terms: The chaperone finds its partner protein and hands over the copper.
Copper chaperone activity requires direct interaction with a target protein, as defined by GO:0016531. CCS delivers copper to SOD1, and this delivery is necessary for SOD1 activity. Atox1 transfers copper to ATP7B, regulating the transporter's activity through modulation of domain dynamics. SCO1 functions in mitochondrial copper delivery, and its activity is connected to AMPK-LKB1 signaling.
Mitochondrial copper delivery
In simple terms: Some chaperones carry copper into mitochondria for use by mitochondrial enzymes.
Copper chaperone for SOD1-1 can transfer copper to mitochondria, but this transfer does not affect cytochrome c oxidase activity, indicating specificity in mitochondrial copper handling. SCO1 is part of a mitochondrial copper delivery pathway that can influence metabolic signaling through AMPK-LKB1. These findings highlight that copper chaperone activity is compartmentalized and target-specific [5,7].
Integration with redox and autophagy pathways
In simple terms: Copper chaperone activity is connected to how cells handle stress and recycle damaged parts.
Copper metabolism, including chaperone-mediated delivery, is integrated with cell death and autophagy pathways. SOD1, a major target of CCS, plays roles in redox signaling and vascular function, linking copper chaperone activity to oxidative stress responses. Dysregulation of these pathways can contribute to neurodegeneration and metabolic disease [1,4,5].
Regulation of copper chaperone availability
In simple terms: Cells adjust how much chaperone is present and how active it is.
High fat conditions can suppress SOD1 activity by reducing copper chaperone for SOD1, linking nutritional status to chaperone function and neurodegeneration. Atox1 has multiple roles and is considered a potential therapeutic target, suggesting its levels or activity are subject to regulation in disease contexts. Golgi-targeted copper delivery strategies can enhance copper-dependent protein activity, indicating that subcellular localization of copper delivery is a regulatory node.
Key Genes Involved in GO:0016531 copper chaperone activity
The following genes and proteins are central to copper chaperone activity (GO:0016531) and its downstream biology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CCS | Copper chaperone for SOD1; delivers copper to SOD1 | Linked to SOD1 activity, neurodegeneration, and memory decline |
| Atox1 | Copper chaperone that delivers copper to ATP7B and participates in signaling | Regulates ATP7B domain dynamics; potential therapeutic target [6,8] |
| SCO1 | Mitochondrial copper delivery protein | Connects copper delivery to AMPK-LKB1 signaling and NAFLD |
| SCO2 | Mitochondrial copper delivery protein | Involved in cytochrome c oxidase assembly and copper homeostasis |
| COX17 | Copper chaperone for mitochondrial cytochrome c oxidase assembly | Required for mitochondrial copper delivery and respiration |
| SOD1 | Cu/Zn superoxide dismutase; receives copper from CCS | Redox signaling, vascular function, and neurodegeneration [2,4] |
| ATP7B | Copper-transporting ATPase; receives copper from Atox1 | Copper export and Wilson disease biology |
| ATP7A | Copper-transporting ATPase | Copper homeostasis and Menkes disease biology |
| MT1A | Metallothionein; copper storage and buffering | Modulates free copper availability for chaperones |
| MT2A | Metallothionein; copper storage and buffering | Modulates free copper availability for chaperones |
| COMMD1 | Copper metabolism regulator | Interacts with copper homeostasis pathways |
| XIAP | Copper-binding protein with roles in cell death | Connects copper metabolism to apoptosis |
| CP | Ceruloplasmin; copper-containing ferroxidase | Linked to NAFLD via SCO1-AMPK-LKB1 complex |
| LDHA | Lactate dehydrogenase A; copper-binding metabolic enzyme | Copper-dependent metabolic regulation |
| ULK1 | Autophagy kinase; copper-regulated | Connects copper metabolism to autophagy |
| MAP1LC3B | Autophagy marker; affected by copper metabolism | Readout of copper-dependent autophagy |
| SQSTM1 | Autophagy receptor; affected by copper metabolism | Readout of copper-dependent autophagy |
How Is copper chaperone activity Regulated?
Copper chaperone activity is regulated at multiple levels, including copper availability, chaperone expression, and subcellular localization [1,3,4]. High fat conditions can reduce copper chaperone for SOD1, thereby suppressing SOD1 activity and contributing to neurodegeneration and memory decline. Atox1 levels and activity are linked to disease states and are considered a therapeutic target, indicating regulation in pathophysiological contexts. Golgi-targeted copper delivery can enhance copper-dependent protein activity, showing that localization of copper delivery is a regulatory mechanism. Copper metabolism is also integrated with autophagy and cell death pathways, which can influence chaperone function indirectly.
copper chaperone activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CCS | Neurodegeneration and memory decline | Knockout or knockdown in neuronal cells; high-fat diet models |
| SCO1 | NAFLD and metabolic signaling | Liver-specific knockout or overexpression; AMPK-LKB1 pathway readouts |
| Atox1 | Copper metabolism disorders and cancer | Knockout or point-mutation models; ATP7B interaction assays [6,8] |
| ATP7B | Wilson disease and copper export defects | Knock-in of disease mutations; copper efflux assays |
| SOD1 | Redox signaling and vascular disease | Overexpression or knockout; oxidative stress readouts [2,4] |
Neurodegeneration and memory decline
Reduced copper chaperone for SOD1 under high fat conditions suppresses SOD1 activity and is associated with neurodegeneration and memory decline. SOD1 is a major target of CCS, and its dysfunction is linked to redox signaling and vascular disease. These findings suggest that copper chaperone activity is important for neuronal health and cognitive function.
Metabolic liver disease (NAFLD)
Downregulation of hepatic ceruloplasmin ameliorates NAFLD via a SCO1-AMPK-LKB1 complex, linking mitochondrial copper delivery to metabolic signaling. SCO1 is part of the copper chaperone network, and its interaction with AMPK-LKB1 highlights how copper chaperone activity can influence liver metabolism.
Copper metabolism disorders
Atox1 regulates ATP7B activity by modulating domain dynamics, and ATP7B dysfunction is central to copper export disorders. Copper chaperone antioxidant 1 (Atox1) has multiple roles and is a potential therapeutic target, suggesting its involvement in copper-related diseases. Copper metabolism is also integrated with cell death and autophagy, which can contribute to disease pathology.
Tissue regeneration and therapeutic copper delivery
Golgi-targeted copper delivery strategies can enhance copper-dependent protein activity for fascia regeneration, indicating that manipulating copper chaperone-dependent pathways may have regenerative applications. This approach leverages the specificity of copper delivery to improve tissue repair.
From copper chaperone activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CCS cause neurodegeneration? | CCS knockout neuronal cell lines and animal models |
| How does SCO1 regulate AMPK-LKB1 signaling? | SCO1 knockout or overexpression in liver cells |
| Does Atox1 point mutation affect ATP7B activity? | Atox1 point-mutation knock-in cells |
| Can Golgi-targeted copper delivery enhance regeneration? | Knock-in of Golgi-targeting sequences or copper delivery constructs |
| What is the role of copper chaperone in autophagy? | Knockout of copper chaperone genes with autophagy readouts |
| Does SOD1 copper delivery affect mitochondrial function? | CCS knockout with mitochondrial copper and cytochrome c oxidase assays |
How to Study the copper chaperone activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function phenotype | Testing requirement of CCS, Atox1, SCO1 in copper delivery [4,5] |
| Point-mutation knock-in | Effect of specific residues on chaperone function | Dissecting copper-binding motifs |
| Copper transfer assays | Direct copper delivery to target proteins | Validating GO:0016531 activity |
| Western blot | Protein expression and activity markers | SOD1 activity, AMPK-LKB1 signaling [4,5] |
| Autophagy flux assays | Autophagy pathway activity | Linking copper metabolism to autophagy |
| Mitochondrial function assays | Cytochrome c oxidase activity and respiration | Testing mitochondrial copper delivery |
| Fluorescence imaging | Subcellular localization of chaperones | Golgi or mitochondrial copper delivery [3,7] |
| RNA-seq | Transcriptional changes upon chaperone perturbation | Identifying downstream pathways [1,5] |
Genetic knockout and knockdown
CRISPR knockout or RNAi knockdown of copper chaperone genes such as CCS, Atox1, and SCO1 allows researchers to test loss-of-function phenotypes in copper delivery and disease models [4,5]. These approaches can reveal whether a chaperone is required for target protein activity and downstream signaling.
Copper-binding and transfer assays
Biochemical assays can measure copper binding to chaperones and transfer to target proteins, providing direct evidence of GO:0016531 activity. Domain dynamics and conformational changes can be assessed using biophysical methods.
Metabolic and signaling readouts
AMPK-LKB1 signaling, SOD1 activity, and autophagy markers can be measured to link copper chaperone activity to cellular pathways [1,4,5]. These readouts help connect molecular function to disease-relevant phenotypes.
Imaging and subcellular localization
Fluorescent tagging of copper chaperones and target proteins can reveal where copper delivery occurs within cells, such as mitochondria or the Golgi [3,7]. Golgi-targeted copper delivery strategies demonstrate the importance of localization for function.
How CRISPR Can Be Used to Study GO:0016531 copper chaperone activity
Knockout
CRISPR knockout of copper chaperone genes such as CCS, Atox1, and SCO1 can abolish copper delivery to specific targets, revealing essential functions in SOD1 activity, mitochondrial metabolism, and liver signaling [4,5]. These models are useful for testing whether a chaperone is required for a given phenotype.
Point Mutation
Point mutations in copper-binding motifs or interaction interfaces can dissect the molecular basis of copper chaperone activity. For example, mutations in Atox1 can affect ATP7B regulation and domain dynamics. Such models help distinguish copper binding from target delivery.
Knock-in
Knock-in of tagged or disease-associated variants allows tracking of copper chaperones and their targets in native contexts [3,6]. Golgi-targeted copper delivery constructs can be knocked in to enhance copper-dependent protein activity for regeneration. Knock-in models are valuable for studying localization and interaction dynamics.
Overexpression
Overexpression of copper chaperones or their targets can test gain-of-function effects on copper delivery and downstream pathways [4,5]. For example, overexpression of SCO1 or CCS can modulate SOD1 activity and metabolic signaling [4,5]. These models complement knockout studies to establish causality.
How EDITGENE Supports copper chaperone activity Research
Researchers studying copper chaperone activity-related genes often need to determine whether a candidate gene is causally involved in copper delivery, target protein maturation, or disease phenotypes. EDITGENE provides CRISPR-based cell models and screening services to enable these causal experiments.
Contact EDITGENE today to design your custom CRISPR model for copper chaperone activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| ATOX1 Knockout HEK293 Cell Line | EDJ-KQ2078 | Human | 475 | Details Get a Quote |
| ATOX1 Knockout A-549 Cell Line | EDJ-KQ23537 | Human | 475 | Details Get a Quote |
| ATOX1 Knockout HCT 116 Cell Line | EDJ-KQ23538 | Human | 475 | Details Get a Quote |
| ATOX1 Knockout HeLa Cell Line | EDJ-KQ23539 | Human | 475 | Details Get a Quote |
| COX17 Knockout HEK293 Cell Line | EDJ-KQ50927 | Human | 10063 | Details Get a Quote |
| COX17 Knockout HeLa Cell Line | EDJ-KQ55310 | Human | 10063 | Details Get a Quote |
| COX17 Knockout A-549 Cell Line | EDJ-KQ63793 | Human | 10063 | Details Get a Quote |
| COX17 Knockout HCT 116 Cell Line | EDJ-KQ72250 | Human | 10063 | Details Get a Quote |
Displaying Records 1 To 8 Of 8 Records
Frequently Asked Questions About copper chaperone activity
What is copper chaperone activity?
Copper chaperone activity (GO:0016531) is the molecular function of directly binding to and delivering copper ions to a target protein.
What genes are involved in copper chaperone activity?
Key genes include CCS, Atox1, SCO1, SCO2, and COX17, which deliver copper to targets such as SOD1, ATP7B, and mitochondrial proteins [1,4,5,6].
How does CCS deliver copper to SOD1?
CCS binds copper and directly transfers it to SOD1, which is required for SOD1 activity; reduced CCS is linked to neurodegeneration.
What is the role of Atox1 in copper metabolism?
Atox1 is a copper chaperone that delivers copper to ATP7B and regulates its activity by modulating domain dynamics.
How is copper chaperone activity linked to disease?
Dysregulation of copper chaperones is associated with neurodegeneration, NAFLD, and copper metabolism disorders [4,5,8].
What is the difference between copper chaperone and copper transporter?
A copper chaperone directly binds and delivers copper to a target protein, while a copper transporter moves copper across membranes [1,6].
Can CRISPR be used to study copper chaperone activity?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models can test the causal role of copper chaperone genes [3,5,6].
What methods measure copper chaperone activity?
Copper transfer assays, biophysical methods, and downstream activity readouts such as SOD1 activity or AMPK-LKB1 signaling can measure chaperone function [4,5,6].
Is SCO1 a copper chaperone?
SCO1 functions in mitochondrial copper delivery and is part of the copper chaperone network, linking to AMPK-LKB1 signaling.
What diseases are linked to copper chaperone dysfunction?
Neurodegeneration, memory decline, NAFLD, and copper export disorders such as Wilson disease biology are linked to copper chaperone dysfunction [4,5,6].
Conclusion
Copper chaperone activity (GO:0016531) is a specialized molecular function that ensures copper ions are delivered directly to target proteins, protecting cells from copper toxicity and enabling cuproprotein maturation [1,2]. Key chaperones such as CCS, Atox1, and SCO1 are linked to neurodegeneration, metabolic liver disease, and copper metabolism disorders [4,5,6,8]. CRISPR-based models provide powerful tools to dissect these mechanisms and identify therapeutic opportunities [3,5].
References
- 1. Xue Q et al.. 2023. Copper metabolism in cell death and autophagy.. Autophagy 19(8):2175-2195 PMID: 37055935
- 2. Fukai T et al.. 2011. Superoxide dismutases: role in redox signaling, vascular function, and diseases.. Antioxid Redox Signal 15(6):1583-606 PMID: 21473702
- 3. Wang R et al.. 2026. Golgi-targeted copper delivery strategy via enhancing copper-dependent proteins' activity for fascia regeneration.. J Control Release 390:114521 PMID: 41371501
- 4. Lu P et al.. 2021. High fat suppresses SOD1 activity by reducing copper chaperone for SOD1 associated with neurodegeneration and memory decline.. Life Sci 272:119243 PMID: 33607157
- 5. Xie L et al.. 2022. Downregulation of hepatic ceruloplasmin ameliorates NAFLD via SCO1-AMPK-LKB1 complex.. Cell Rep 41(3):111498 PMID: 36261001
- 6. Yu CH et al.. 2017. The metal chaperone Atox1 regulates the activity of the human copper transporter ATP7B by modulating domain dynamics.. J Biol Chem 292(44):18169-18177 PMID: 28900031
- 7. Wang B et al.. 2013. Copper chaperone for superoxide dismutase-1 transfers copper to mitochondria but does not affect cytochrome c oxidase activity.. Exp Biol Med (Maywood) 238(9):1017-23 PMID: 23900152
- 8. Yang D et al.. 2023. Copper chaperone antioxidant 1: multiple roles and a potential therapeutic target.. J Mol Med (Berl) 101(5):527-542 PMID: 37017692
